Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medicskin Holdings's Enterprise Value is HK$49.64 Mil.
Medicskin Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was HK$1.82 Mil. Therefore, Medicskin Holdings's EV-to-EBIT ratio for today is 27.24.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medicskin Holdings's Enterprise Value is HK$49.64 Mil.
Medicskin Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was HK$8.99 Mil. Therefore, Medicskin Holdings's EV-to-EBITDA ratio for today is 5.52.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medicskin Holdings's Enterprise Value is HK$49.64 Mil.
Medicskin Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was HK$47.87 Mil. Therefore, Medicskin Holdings's EV-to-Revenue ratio for today is 1.04.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medicskin Holdings (HKSE:08307) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was HK$1.82 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was HK$8.99 Mil.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was HK$47.87 Mil.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was HK$5.51 Mil.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was HK$4.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicskin Holdings Enterprise Value Related Terms
Medicskin Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medicskin Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08307 vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Medicskin Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicskin Holdings Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicskin Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medicskin Holdings's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medicskin Holdings's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$49.64 Mil mean?
Medicskin Holdings (HKSE:08307) has a Enterprise Value of HK$49.64 Mil as of Aug. 12, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicskin Holdings and its competitors.
Is Medicskin Holdings' Enterprise Value too high?
Medicskin Holdings' current Enterprise Value is HK$49.64 Mil. Overall, Medicskin Holdings has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicskin Holdings' Enterprise Value compare to HCA and THC?
Medicskin Holdings' Enterprise Value of HK$49.64 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicskin Holdings and its competitors. Medicskin Holdings's current Enterprise Value is HK$49.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicskin Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medicskin Holdings (HKSE:08307) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.18, compared to a current price of HK$0.12 — trading 31.7% below its estimated fair value. The current Enterprise Value is HK$49.64 Mil. Medicskin Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medicskin Holdings (HKSE:08307), the current Enterprise Value is HK$49.64 Mil as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicskin Holdings (HKSE:08307) Overvalued in 2026?
Based on GuruFocus' analysis, Medicskin Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 31.7% below its estimated GF Value™ of HK$0.18.
GuruFocus considers Medicskin Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08307:
Enterprise Value: HK$49.64 Mil
GF Value™: HK$0.18 vs. price of HK$0.12 (31.7% below fair value)
No single metric tells the full story. See the HKSE:08307 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicskin Holdings Ltd is a medical skin care service provider. It is engaged in providing services for inter alia, acne, pigmentation, rosacea, dermatitis, eczema and warts, skin rejuvenation, facial sculpturing and body contouring, treatment for acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company operates through a single segment namely Consultation Service, Prescription and Dispensing Service, and Treatment Services. The company offers services throughout Hong Kong.
54GF Score
Get the complete analysis for HKSE:08307
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08307 has been successfully added to your 
